Home » Stocks » NBIO

Nascent Biotech Inc. (NBIO)

Stock Price: $0.0779 USD 0.0033 (4.42%)
Updated Apr 16, 2021 3:55 PM EDT - Market closed
Market Cap 7.56M
Revenue (ttm) n/a
Net Income (ttm) -4.37M
Shares Out 97.06M
EPS (ttm) -0.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $0.0779
Previous Close $0.0746
Change ($) 0.0033
Change (%) 4.42%
Day's Open 0.0749
Day's Range 0.0710 - 0.0780
Day's Volume 242,157
52-Week Range 0.0437 - 0.1950

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SAN DIEGO, CA / ACCESSWIRE / March 31, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech," "Nascent," or the "Company"), a clinical-stage biotechnology company pioneering the development of mo...

2 weeks ago - Accesswire

SAN DIEGO, CA / ACCESSWIRE / March 24, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company pioneering the development of mo...

3 weeks ago - Accesswire

SAN DIEGO, CA / ACCESSWIRE / March 2, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company pioneering the development of mon...

1 month ago - Accesswire

Nascent Biotech Inc (OTCMKTS: NBIO) has announced the publication of promising in-vitro study results from its pritumumab (PTB) research collaboration with Syracuse University, validating the potential ...

2 months ago - Benzinga

About NBIO

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a monoclonal antibody to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as lung and breast cancer metastases to the brain; and pancreatic cancer. The company has a research collaboration agreement with Manhattan BioSolutions, Inc. to initiate a vaccine program for the prevention of COVID-19 or other viral infections; an... [Read more...]

Industry
Biotechnology
Stock Exchange
OTCMKTS
Ticker Symbol
NBIO
Full Company Profile

Financial Performance

Financial Statements